| GLUCAGON RELATED PEPTIDES | |||
CODE |
DESCRIPTION |
QTY |
USD |
PGL-4098-s |
Glucagon
(Human) His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu- Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr M.W. 3482.8 C153H225N43O49S Synthetic Product Lyophilized amorphous powder, purity >95% by HPLC P.J. Lefebvre and R.H. Unger (Eds.), Glucagon, Pergamon Press, Oxford, 1972. (Review) |
0.1 mg vial |
125 |
PGP-4280-v |
Glucagon-like
Peptide 1 (7-37) GLP-1 (7-37) His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu- Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly M.W. 3355.8 C151H228N40O47 Synthetic Product Lyophilized amorphous powder, purity >99% by HPLC G.G. Holz IV, W.M. Kühtreiber, and J.F. Habener, Nature, 361, 362 (1993). |
0.5 mg vial |
305 |
PGL-4344-v |
Glucagon-like
Peptide 1 (7-36 Amide) GLP-1 (7-36 Amide) His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu- Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 M.W. 3297.7 C149H226N40O45 Synthetic Product Lyophilized amorphous powder, purity >99% by HPLC M.D. Turton, D. O’Shea, I. Gunn, S.A. Beak, C.M.B. Edwards, K. Meeran, S.J. Choi, G.M. Taylor, M.M. Heath, P.D. Lambert, J.P.H. Wilding, D.M. Smith, M.A. Ghatei, J. Herbert, and S.R. Bloom, Nature, 379, 69 (1996). (Orginial-CNS Effect on Feeding) M. Tang-Christensen, P.J. Larsen, R. Göke, A. Fink-Jensen, D.S. Jessop, M. Møller, and S.P. Sheikh, Am. J. Physiol., 271, R848 (1996). (Original-CNS Effect on Drinking) G. van Dijk, T.E. Thiele, R.J. Seeley, S.C. Woods, and I.L. Bernstein, Nature, 385, 214 (1997). (Correspondence) |
0.5 mg vial |
305 |
PGL-4376-v New! |
Glucagon-like
Peptide 2 (Human) GLP-2 (Human) His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu- Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln- Thr-Lys-Ile-Thr-Asp MW 3766.10 C165H254N44O55S Synthetic Product Lyophilized amorphous powder, purity >95% by HPLC Food Intake Regulator D.J. Drucker, Trends Endocrinol. Metab., 10, 153 (1999). (Review) B. Hartmann, A.H. Johnsen, C. Ørskov, K. Adelhorst, L. Thim, and J.J. Holst, Peptides, 21, 73 (2000). (Pharmacol.) M. Tang-Christensen, P.J. Larsen, J. Thulesen, J. Rømer, and N. Vrang, Nat. Med., 6, 802 (2000). (Pharmacol.) |
0.5 mg vial |
325 |
Please contact Peptides
International for ordering information. |
